Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €675.10 | €753.63 | 11.632% |
| Boston Scientific | 40 | 0 | 7 | 0 | €68.00 | €72.00 | 5.882% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €367.95 | €382.71 | 4.010% |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €345.60 | €370.00 | 7.060% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €460.15 | €543.72 | 18.161% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 7 | 1 | €824.40 | €957.22 | 16.111% |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €136.98 | €196.74 | 43.624% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €121.00 | €124.92 | 3.236% |
| Thermo Fisher Scientific Inc. | 25 | 0 | 4 | 0 | €534.10 | €565.20 | 5.823% |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €90.50 | €95.79 | 5.850% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €67.00 | €79.43 | 18.552% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €60.50 | €86.72 | 43.331% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €128.30 | €137.63 | 7.275% |
| Edwards Lifesciences Corp. | 24 | 1 | 3 | 0 | €81.15 | €88.14 | 8.611% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €249.75 | €294.28 | 17.831% |
| Humana Inc. | 22 | 0 | 5 | 0 | €287.80 | €465.93 | 61.895% |
| R1 RCM Inc. | 19 | 0 | 3 | 0 | €11.00 | €17.21 | 56.478% |
| HCA Holdings Inc. | 19 | 0 | 2 | 0 | €295.50 | €296.18 | 0.229% |
| Sutro Biopharma Inc | 18 | 0 | 7 | 0 | €3.18 | €11.05 | 247.434% |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €77.00 | €102.55 | 33.186% |
| Dexcom Inc. | 17 | 0 | 2 | 0 | €126.08 | €136.81 | 8.511% |
| Stryker Corp. | 17 | 0 | 4 | 0 | €312.60 | €331.52 | 6.054% |
| AbbVie Inc. | 18 | 1 | 2 | 1 | €155.10 | €175.79 | 13.338% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.70 | - | - |